Recent evidence also suggests that inhibition of the AhR/NF-κB/JNK axis activates BDNF/TrkB signaling, which attenuates the progression of CKD and the cognitive deficits associated with CKD (Gu et al., 2022). Here, NFKB1 is linked to chronic kidney disease.